NGM Biopharmaceuticals, Inc. Common Stock, par value $0.001 per share Underwriting AgreementUnderwriting Agreement • January 6th, 2021 • NGM Biopharmaceuticals Inc • Pharmaceutical preparations • New York
NGM Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 4,629,630 shares (the “Firm Shares”) and, at the election of the Underwriters, up to 694,444 additional shares (the “Optional Shares”) of common stock, par value $0.001 per share (“Stock”) of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
